Biostem Technologies

Regenerative medicine company

Based in FL

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $590K in lobbying spend across 7 quarterly filings, Biostem Technologies is an active lobbying client. Their lobbying covers 1 issue area. Active from 2024 to 2025.

$590K
Total Spend
2
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2024$160K
2025$430K

Issues Lobbied

Medicare/Medicaid

Lobbying Firms

Ballard Partners

Lobbyists

Brian BallardSylvester Lukis

Government Agencies Targeted

These are the government entities that Biostem Technologies disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESHealth & Human Services, Dept of (HHS)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid

Advocated for medicare reimbursement for skin substitutes that are used to heal wounds caused from diabetes.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Apotex Corp.
$9.0M total spend
Blue Cross and Blue Shield of Florida INC
$7.4M total spend
Baycare Health System
$6.8M total spend
Vitas Healthcare Corporation
$3.9M total spend
Lincare
$2.6M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.